Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: a single-blind, randomized study.

@article{Krymchantowski2008LysineCV,
  title={Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: a single-blind, randomized study.},
  author={Abouch V Krymchantowski and Henrique Figueiredo Carneiro and Jackeline Soraya Barbosa and Carla da Cunha Jevoux},
  journal={Arquivos de neuro-psiquiatria},
  year={2008},
  volume={66 2A},
  pages={
          216-20
        }
}
BACKGROUND AND OBJECTIVE Nonsteroidal anti-inflammatory drugs (NSAID) are effective to treat migraine attacks. Lysine clonixinate (LC) and dipyrone (metamizol) have been proven effective to treat acute migraine. The aim of this study was to evaluate the efficacy and tolerability of the intravenous formulations of LC and dipyrone in the treatment of severe migraine attacks. METHOD Thirty patients (28 women, 2 men), aged 18 to 48 years with migraine according the International Headache Society… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Epidemiology of headache.

  • Cephalalgia : an international journal of headache
  • 2001

Analgesics . In Diener HC ( Eed ) . Drug treatment of migraine and other headaches

V Limmroth, S Przywara
  • Monogr Clin Neurosci
  • 2000

Similar Papers

Loading similar papers…